Suscribirse

An involvement of Hippo-yes-associated protein pathway in biliary epithelial senescence in primary biliary cholangitis - 31/03/23

Doi : 10.1016/j.clinre.2023.102106 
Motoko Sasaki a, , Yasunori Sato a, Yasuni Nakanuma b
a Department of Human Pathology, Kanazawa University Graduate School of Medical Sciences, Kanazawa, 920-8640, Japan 
b Department of Pathology, Fukui Saiseikai Hospital, Fukui 918-8503, Japan 

Corresponding author.

Highlights

Expression and activity of YAP1 were significantly decreased in senescent BECs.
Cellular senescence and apoptosis were increased by a knockdown of YAP1 in BECs.
The expression of YAP1 was decreased in senescent BECs in bile duct lesions in PBC.
Dysregulation of Hippo-YAP1 pathway may be involved in the pathogenesis of PBC.

El texto completo de este artículo está disponible en PDF.

Abstract

Background & Aims

Accumulating evidence suggest that Hippo-yes-associated protein (YAP) pathway plays important roles in development and repair after injuries in biliary system. We disclosed that senescent biliary epithelial cells (BECs) participate in the pathogenesis of primary biliary cholangitis (PBC). We hypothesized that dysregulation of Hippo-YAP pathway may be associated with biliary epithelial senescence in pathogenesis of PBC.

Approach & Results

Cellular senescence was induced in cultured BECs by treatment with serum depletion or glycochenodeoxycholic acid. The expression and activity of YAP1 were significantly decreased in senescent BECs (p<0.01). Cellular senescence and apoptosis were significantly increased (p<0.01) and a proliferation activity and a 3D-cyst formation activity were significantly decreased (p<0.01) by a knockdown of YAP1 in BECs. The expression of YAP1 were immunohistochemically determined in livers taken from the patients with PBC (n = 79) and 79 control diseased and normal livers and its association with senescent markers p16INK4a and p21WAF1/Cip1 was analyzed. The nuclear expression of YAP1, which indicates activation of YAP1, was significantly decreased in BECs in small bile ducts involved in cholangitis and ductular reactions in PBC, compared to control livers (p<0.01). The decreased expression of YAP1 was seen in senescent BECs showing expression of p16INK4a and p21WAF1/Cip1 in bile duct lesions.

Conclusion

Dysregulation of Hippo-YAP1 pathway may be involved in the pathogenesis of PBC in association with biliary epithelial senescence.

El texto completo de este artículo está disponible en PDF.

Keywords : Primary biliary cholangitis (PBC), Yes-associated protein 1 (YAP1), Cellular senescence, p16INK4a, p21WAF1/Cip1, Biliary epithelial cells


Esquema


© 2023  Elsevier Masson SAS. Reservados todos los derechos.
Añadir a mi biblioteca Eliminar de mi biblioteca Imprimir
Exportación

    Exportación citas

  • Fichero

  • Contenido

Vol 47 - N° 4

Artículo 102106- avril 2023 Regresar al número
Artículo precedente Artículo precedente
  • Characteristics of infections and their risk factors in children with biliary atresia
  • Henry Shiau, Jeremy M. Schraw, Krupa Mysore, Laurel Cavallo, Sanjiv Harpavat, Philip J. Lupo, Flor M. Munoz, Benjamin L. Shneider
| Artículo siguiente Artículo siguiente
  • Timing of minimally invasive step-up intervention for symptomatic pancreatic necrotic fluid collections: A systematic review and meta-analysis
  • ZheYu Liu, Pi Liu, Xuan Xu, Qian Yao, YuWen Xiong

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.

¿Ya suscrito a @@106933@@ revista ?

Mi cuenta


Declaración CNIL

EM-CONSULTE.COM se declara a la CNIL, la declaración N º 1286925.

En virtud de la Ley N º 78-17 del 6 de enero de 1978, relativa a las computadoras, archivos y libertades, usted tiene el derecho de oposición (art.26 de la ley), el acceso (art.34 a 38 Ley), y correcta (artículo 36 de la ley) los datos que le conciernen. Por lo tanto, usted puede pedir que se corrija, complementado, clarificado, actualizado o suprimido información sobre usted que son inexactos, incompletos, engañosos, obsoletos o cuya recogida o de conservación o uso está prohibido.
La información personal sobre los visitantes de nuestro sitio, incluyendo su identidad, son confidenciales.
El jefe del sitio en el honor se compromete a respetar la confidencialidad de los requisitos legales aplicables en Francia y no de revelar dicha información a terceros.


Todo el contenido en este sitio: Copyright © 2024 Elsevier, sus licenciantes y colaboradores. Se reservan todos los derechos, incluidos los de minería de texto y datos, entrenamiento de IA y tecnologías similares. Para todo el contenido de acceso abierto, se aplican los términos de licencia de Creative Commons.